Angus S. King, Jr. sold Teva Pharma Industries Ltd ADR (NYSE: TEVA)
Angus S. King, Jr. (I-ME), a U.S. Senator, has disclosed 1 trade in Teva Pharma Industries Ltd ADR (TEVA) since 2016, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Angus S. King, Jr. sold $1,001 - $15,000 of Teva Pharma Industries Ltd ADR (NYSE: TEVA) on October 19, 2016. Since that trade, TEVA is down -16.45% against the S&P 500 up +296.62%, an outperformance of -313.07%.
Data updated
Angus S. King, Jr.'s TEVA trades vs the price
TEVA is down -16.45% since Angus S. King, Jr. sold on October 19, 2016, versus +296.62% for the S&P 500.
Performance since this trade
All Angus S. King, Jr. TEVA trades
Angus S. King, Jr. & TEVA trading FAQ
Is it legal for Angus S. King, Jr. to trade Teva Pharma Industries Ltd ADR (TEVA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Teva Pharma Industries Ltd ADR (TEVA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Angus S. King, Jr. sell TEVA?
Angus S. King, Jr. disclosed a sale of $1,001 - $15,000 of Teva Pharma Industries Ltd ADR (TEVA) on October 19, 2016, according to public STOCK Act filings.
How has TEVA performed since Angus S. King, Jr.'s trade?
Since Angus S. King, Jr. sold TEVA on October 19, 2016, the stock is down -16.45%, versus +296.62% for the S&P 500 over the same period, an outperformance of -313.07%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional TEVA trades?
Quantellect tracks every disclosed congressional trade in Teva Pharma Industries Ltd ADR (TEVA) on the Teva Pharma Industries Ltd ADR congressional trading page, which aggregates filings across all members of Congress.
Angus S. King, Jr.'s TEVA tradesAll congressional filings for Teva Pharma Industries Ltd ADRAngus S. King, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.